Orthoptists' management of amblyopia - A case-based survey

Strabismus

Volumn 15, Issue 4, 2007, Pages 197-203

  Georgievski, Zoran ^a,b   Koklanis, Konstandina ^a,c   Leone, Josie ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b NORTHERN HEALTH   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Amblyopia treatment; Atropine; Occlusion; Orthoptics; Patching

Indexed keywords

ATROPINE;

AMBLYOPIA; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CLINICAL DECISION MAKING; CONTROLLED STUDY; HEALTH SURVEY; HUMAN; HYPERMETROPIA; NORMAL HUMAN; ORTHOPTICS; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; REFRACTION ERROR; SPECTACLES; TREATMENT PLANNING; VIGNETTE; VISUAL ACUITY;

AMBLYOPIA; ATROPINE; CHILD; CHILD, PRESCHOOL; HUMANS; MYDRIATICS; ORTHOPTICS; QUESTIONNAIRES; SENSORY DEPRIVATION;

EID: 36749063022     PISSN: 09273972     EISSN: 17445132     Source Type: Journal    
DOI: 10.1080/09273970701631975     Document Type: Article

References (30)

1. Ansons AM, Davis H. Diagnosis and Management of Ocular Motility Disorders, 3rd ed. London, UK: Blackwell Science, 2001.
2. Awan M, Proudlock F, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435-1439.
3. Eibschitz-Tsimhoni M, Friedman T, Naor J, et al. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS. 2000;4:194-199.
4. Foley-Nolan A, McCann A, O'Keefe M. Atropine penalisation versus occlusion as the primary treatment for amblyopia. Br J Ophthalmol. 1997;81:54-57.
5. Holmes J, Beck RW, Kraker RT, et al. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol. 2003;121:1625-1632.
6. Holmes J, Clarke M. Amblyopia. Lancet. 2006;367:1343-1357.
7. Loudon S, Fronius M, Looman C, et al. Predictors and a remedy for noncompliance with amblyopia therapy in children measured with the occlusion dose monitor. Invest Ophthalmol Vis Sci. 2006;47:4393-4400.
8. Loudon S, Polling J-R, Simonsz B, Simonsz H. Objective survey of the prescription of occlusion therapy for amblyopia. Graefes Arch Clin Exp Ophthalmol. 2004;242:736-740.
9. Mazow ML, Chuang A, Vital MC, Prager T. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS. 2000;4:1-9.
10. Moseley M, Neufeld M, McCarry B, et al. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Optics. 2002;22:296-299.
11. Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002a;120:268-278.
12. Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol. 2002b;120:281-287.
13. Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: experience of the amblyopia treatment study. Am J Ophthalmol. 2003a;136:630-639.
14. Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003b;110:2075-2087.
15. Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology. 2003c;110:1632-1637.
16. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003d;121:603-611.
17. Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS. 2004a;8:420-428.
18. Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology. 2004b;111:2076-2085.
19. Pediatric Eye Disease Investigator Group. A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol. 2004c;137:581-583.
20. Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS. 2005a;9:129-136.
21. Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005b;123:437-447.
22. Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2005c;123:149-157.
23. Scheiman MM, Hertle RW, Beck RW, et al. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005;123:437-447.
24. Simons K, Stein L, Sener EC, et al. Full-time atropine, intermittent atropine, and optical penalization and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997a;104:2143-55.
25. Simons K, Gotzler KC, Vitale S. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology. 1997b;104:2156-2160.
26. Stewart C, Moseley M, Stephens D, Fielder A. Treatment dose-response in amblyopia therapy: the monitored occlusion treatment of amblyopia study (MOTAS). Invest Ophthalmol Vis Sci. 2004a;45:3048-3054.
27. Stewart C, Moseley M, Fielder A, et al. Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol. 2004b;88:1552-1556.
28. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005;46:3152-3160.
29. Tan JHY, Thompson JR, Gottlob I. Differences in the management of amblyopia between European countries. Br J Ophthalmol. 2003;87:291-296.
30. Wickham L, Stewart C, Charnock A, Fielder A. The assessment and management of strabismus and amblyopia: a national audit. Eye. 2002;16:522-529.